419 related articles for article (PubMed ID: 9815853)
61. Mechanisms of c-erbB2/neu oncogene-induced metastasis and repression of metastatic properties by adenovirus 5 E1A gene products.
Yu D; Hamada J; Zhang H; Nicolson GL; Hung MC
Oncogene; 1992 Nov; 7(11):2263-70. PubMed ID: 1359495
[TBL] [Abstract][Full Text] [Related]
62. Phytosterols reduce in vitro metastatic ability of MDA-MB-231 human breast cancer cells.
Awad AB; Williams H; Fink CS
Nutr Cancer; 2001; 40(2):157-64. PubMed ID: 11962251
[TBL] [Abstract][Full Text] [Related]
63. Collagen-induced morphogenesis and expression of the alpha 2-integrin subunit is inhibited in c-erbB2-transfected human mammary epithelial cells.
D'Souza B; Berdichevsky F; Kyprianou N; Taylor-Papadimitriou J
Oncogene; 1993 Jul; 8(7):1797-806. PubMed ID: 8099725
[TBL] [Abstract][Full Text] [Related]
64. A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks crosstalk with growth factor receptors.
Klapper LN; Vaisman N; Hurwitz E; Pinkas-Kramarski R; Yarden Y; Sela M
Oncogene; 1997 May; 14(17):2099-109. PubMed ID: 9160890
[TBL] [Abstract][Full Text] [Related]
65. c-erbB2 amplification and overexpression in human tumors.
Lofts FJ; Gullick WJ
Cancer Treat Res; 1992; 61():161-79. PubMed ID: 1360230
[TBL] [Abstract][Full Text] [Related]
66. CD44 mediates human glioma cell adhesion and invasion in vitro.
Merzak A; Koocheckpour S; Pilkington GJ
Cancer Res; 1994 Aug; 54(15):3988-92. PubMed ID: 7518347
[TBL] [Abstract][Full Text] [Related]
67. Expression of c-erbB family gene products in adenoid cystic carcinoma of salivary glands: an immunohistochemical study.
Shintani S; Funayama T; Yoshihama Y; Alcalde RE; Ootsuki K; Terakado N; Matsumura T
Anticancer Res; 1995; 15(6B):2623-6. PubMed ID: 8669836
[TBL] [Abstract][Full Text] [Related]
68. The biological and biochemical effects of CP-654577, a selective erbB2 kinase inhibitor, on human breast cancer cells.
Barbacci EG; Pustilnik LR; Rossi AM; Emerson E; Miller PE; Boscoe BP; Cox ED; Iwata KK; Jani JP; Provoncha K; Kath JC; Liu Z; Moyer JD
Cancer Res; 2003 Aug; 63(15):4450-9. PubMed ID: 12907618
[TBL] [Abstract][Full Text] [Related]
69. Comparison of in vitro invasiveness of human breast carcinoma in early or late stage with their malignancy in vivo.
Le Marer N; Bruyneel E
Anticancer Res; 1996; 16(5A):2767-72. PubMed ID: 8917384
[TBL] [Abstract][Full Text] [Related]
70. Effects of the carbohydrate-binding protein galectin-3 on the invasiveness of human breast carcinoma cells.
Le Marer N; Hughes RC
J Cell Physiol; 1996 Jul; 168(1):51-8. PubMed ID: 8647922
[TBL] [Abstract][Full Text] [Related]
71. Heregulin induces increase in sensitivity of an erbB-2-overexpressing breast cancer cell type to lysis by lymphokine-activated killer cells.
Cardillo M; Yankelevich B; Mazumder A; Lupu R
Cancer Immunol Immunother; 1996 Sep; 43(1):19-25. PubMed ID: 8917631
[TBL] [Abstract][Full Text] [Related]
72. Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines.
Momeny M; Saunus JM; Marturana F; McCart Reed AE; Black D; Sala G; Iacobelli S; Holland JD; Yu D; Da Silva L; Simpson PT; Khanna KK; Chenevix-Trench G; Lakhani SR
Oncotarget; 2015 Feb; 6(6):3932-46. PubMed ID: 25668816
[TBL] [Abstract][Full Text] [Related]
73. A ligand for the erbB-2 oncogene product (gp30) induces differentiation of human breast cancer cells.
Bacus SS; Huberman E; Chin D; Kiguchi K; Simpson S; Lippman M; Lupu R
Cell Growth Differ; 1992 Jul; 3(7):401-11. PubMed ID: 1358180
[TBL] [Abstract][Full Text] [Related]
74. Expression of the erbB-2 family of growth factor receptors and their ligands in breast cancers. Implication for tumor biology and clinical behavior.
Bacus SS; Zelnick CR; Plowman G; Yarden Y
Am J Clin Pathol; 1994 Oct; 102(4 Suppl 1):S13-24. PubMed ID: 7942609
[TBL] [Abstract][Full Text] [Related]
75. Clinical implications of the influence of Ehm2 on the aggressiveness of breast cancer cells through regulation of matrix metalloproteinase-9 expression.
Yu H; Ye L; Mansel RE; Zhang Y; Jiang WG
Mol Cancer Res; 2010 Nov; 8(11):1501-12. PubMed ID: 21047774
[TBL] [Abstract][Full Text] [Related]
76. Epidermal growth factor mediates detachment from and invasion through collagen I and Matrigel in Capan-1 pancreatic cancer cells.
Shirk AJ; Kuver R
BMC Gastroenterol; 2005 Mar; 5():12. PubMed ID: 15801978
[TBL] [Abstract][Full Text] [Related]
77. [Role of p185c-erbB2 in endometrial cancer growth in vitro].
Sakamoto H; Ohtani K; Ohta H; Takami M; Takami T; Satoh K
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jul; 44(7):800-4. PubMed ID: 1354238
[TBL] [Abstract][Full Text] [Related]
78. Liarozole and 13-cis-retinoic acid anti-prostatic tumor activity.
Stearns ME; Wang M; Fudge K
Cancer Res; 1993 Jul; 53(13):3073-7. PubMed ID: 8319215
[TBL] [Abstract][Full Text] [Related]
79. Effective suppression of breast tumor growth by an anti-EGFR/ErbB2 bispecific antibody.
Wang S; Chen C; Meng Y; Hu S; Zheng L; Song J; Zhang D; Li B; Guo Y
Cancer Lett; 2012 Dec; 325(2):214-9. PubMed ID: 22789781
[TBL] [Abstract][Full Text] [Related]
80. Radioimmunotherapy of breast cancer xenografts with monoclonal antibody ICR12 against c-erbB2 p185: comparison of iodogen and N-succinimidyl 4-methyl-3-(tri-n-butylstannyl)benzoate radioiodination methods.
Smellie WJ; Dean CJ; Sacks NP; Zalutsky MR; Garg PK; Carnochan P; Eccles SA
Cancer Res; 1995 Dec; 55(23 Suppl):5842s-5846s. PubMed ID: 7493357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
